The individual survival benefits of tumor necrosis factor soluble receptor and fluid administration are not additive in a rat sepsis model

Intensive Care Medicine

Volumn 37, Issue 10, 2011, Pages 1688-1695

  Qiu, Ping ^a   Li, Yan ^a   Ding, Yi ^a   Weng, Jia ^a   Banks, Steven M ^a   Kern, Steven ^a   Fitz, Yvonne ^a   Suffredini, Anthony F ^a   Eichacker, Peter Q ^a   Cui, Xizhong ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Bacterial infection; Fluid support; Pneumonia; Rat; Sepsis; TNF soluble receptor

Indexed keywords

CEFTRIAXONE; FC RECEPTOR; HUMAN SERUM ALBUMIN; HYBRID PROTEIN; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BLOOD CELL COUNT; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI INFECTION; FLUID THERAPY; HEART RATE; HEMODYNAMICS; HOST RESISTANCE; LACTATE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; SEPSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

ANIMALS; COMBINED MODALITY THERAPY; FLUID THERAPY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SEPSIS; SURVIVAL RATE;

EID: 80054857718     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2324-z     Document Type: Article

References (30)

1. Vicaut E, Hou X, Payen D, Bousseau A, Tedgui A (1991) Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. J Clin Invest 87:1537-1540
2. Natanson C, Eichenholz PW, Danner RL, Eichacker PQ, Hoffman WD, Kuo GC, Banks SM, MacVittie TJ, Parrillo JE (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169:823-832 (Pubitemid 19085823)
3. Eichacker PQ, Hoffman WD, Farese A, Banks SM, Kuo GC, MacVittie TJ, Natanson C (1991) TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol 71:1979-1989
4. Naziri W, Joshua IG (1998) Role of tumor necrosis factor-alpha in small intestinal microcirculation. Am Surg 64:203-209 discussion 209-210
5. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664 (Pubitemid 18005583)
6. Eichacker PQ, Parent C, Kalil A, Esposito C, Cui X, Banks SM, Gerstenberger EP, Fitz Y, Danner RL, Natanson C (2002) Risk and the efficacy of antiinflammatory agents: Retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med 166:1197-1205 (Pubitemid 35222596)
7. Bagby GJ, Plessala KJ, Wilson LA, Thompson JJ, Nelson S (1991) Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis. J Infect Dis 163:83-88
8. Karzai W, Cui X, Mehlhorn B, Straube E, Hartung T, Gerstenberger E, Banks SM, Natanson C, Reinhart K, Eichacker PQ (2003) Protection with antibody to tumor necrosis factor differs with similarly lethal Escherichia coli versus Staphylococcus aureus pneumonia in rats. Anesthesiology 99:81-89 (Pubitemid 36799037)
9. Piper RD, Cook DJ, Bone RC, Sibbald WJ (1996) Introducing critical appraisal to studies of animal models investigating novel therapies in sepsis. Crit Care Med 24:2059-2070 (Pubitemid 26418902)
10. Dorresteijn MJ, van Eijk LT, Netea MG, Smits P, van der Hoeven JG, Pickkers P (2005) Iso-osmolar prehydration shifts the cytokine response towards a more antiinflammatory balance in human endotoxemia. J Endotoxin Res 11:287-293 (Pubitemid 41556036)
11. Wilson MA, Chou MC, Spain DA, Downard PJ, Qian Q, Cheadle WG, Garrison RN (1996) Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma 41:622-627 (Pubitemid 26346291)
12. Sherer K, Li Y, Cui X, Li X, Subramanian M, Laird MW, Moayeri M, Leppla SH, Fitz Y, Su J, Eichacker PQ (2007) Fluid support worsens outcome and negates the benefit of protective antigen-directed monoclonal antibody in a lethal toxin-infused rat Bacillus anthracis shock model. Crit Care Med 35:1560-1567 (Pubitemid 46809321)
13. Li Y, Li X, Haley M, Fitz Y, Gerstenberger E, Banks SM, Eichacker PQ, Cui X (2006) DTPA Fe(III) decreases cytokines and hypotension but worsens survival with Escherichia coli sepsis in rats. Intensive Care Med 32:1263-1270 (Pubitemid 44232424)
14. Haley M, Parent C, Cui X, Kalil A, Fitz Y, Correa-Araujo R, Natanson C, Danner RL, Banks SM, Eichacker PQ (2005) Neutrophil inhibition with L-selectin-directed MAb improves or worsens survival dependent on the route but not severity of infection in a rat sepsis model. J Appl Physiol 98:2155-2162 (Pubitemid 40726910)
15. Cui X, Zeni F, Vodovitz Y, Correa-de- Araujo R, Quezado M, Roberts A, Wahl S, Danner RL, Banks SM, Gerstenberger E, Fitz Y, Natanson C, Eichacker PQ (2003) TGF-beta1 increases microbial clearance but worsens lung injury during Escherichia coli pneumonia in rats. Cytokine 24:115-127 (Pubitemid 37297875)
16. Cui X, Li Y, Li X, Haley M, Moayeri M, Fitz Y, Leppla SH, Eichacker PQ (2006) Sublethal doses of Bacillus anthracis lethal toxin inhibit inflammation with lipopolysaccharide and Escherichia coli challenge but have opposite effects on survival. J Infect Dis 193:829-840
17. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655
18. Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR (1995) Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med 23:1512-1518
19. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296-327
20. Murphy CV, Schramm GE, Doherty JA, Reichley RM, Gajic O, Afessa B, Micek ST, Kollef MH (2009) The importance of fluid management in acute lung injury secondary to septic shock. Chest 136:102-109
21. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M (2001) Early goaldirected therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377
22. Cui X, Solomon S, Natanson C, Fitz Y, Danner RL, Gerstenberger E, Banks S, Eichacker PQ (2002) Oligonuleotide microarrays identify genes, including one for TNFsr, with changes in expression dependent on infection dose of E. coli in rats. Am J Crit Care Med 165:A521
23. Cui X, Parent C, Macarthur H, Ochs SD, Gerstenberg E, Solomon S, Fitz Y, Danner RL, Banks SM, Natanson C, Salvemini D, Eichacker PQ (2004) Severity of sepsis alters the effects of superoxide anion inhibition in a rat sepsis model. J Appl Physiol 97:1349-1357 (Pubitemid 39299351)
24. Natanson C, Danner RL, Reilly JM, Doerfler ML, Hoffman WD, Akin GL, Hosseini JM, Banks SM, Elin RJ, MacVittie TJ et al (1990) Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol 259:H1440-H1447 (Pubitemid 20385744)
25. Evans DA, Jacobs DO, Revhaug A, Wilmore DW (1989) The effects of tumor necrosis factor and their selective inhibition by ibuprofen. Ann Surg 209:312-321 (Pubitemid 19083499)
26. Poon KS, Pang CC (2002) Venodilator action of an organotransition-metal nitrosyl complex. Eur J Pharmacol 436:107-110 (Pubitemid 34142404)
27. Bemelmans MH, Gouma DJ, Buurman WA (1993) Influence of nephrectomy on tumor necrosis factor clearance in a murine model. J Immunol 150:2007-2017 (Pubitemid 23129679)
28. Knotek M, Rogachev B, Wang W, Ecder T, Melnikov V, Gengaro PE, Esson M, Edelstein CL, Dinarello CA, Schrier RW (2001) Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase. Kidney Int 59:2243-2249 (Pubitemid 32467617)
29. Wang W, Zolty E, Falk S, Basava V, Reznikov L, Schrier R (2006) Pentoxifylline protects against endotoxin-induced acute renal failure in mice. Am J Physiol Renal Physiol 291:F1090-F1095 (Pubitemid 44772043)
30. Mohler KM, Torrance DS, Smith CA, Goodwin RG, Stremler KE, Fung VP, Madani H, Widmer MB (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151:1548-1561 (Pubitemid 23219293)